Medical Subject Headings

Home > Library Catalogs and Services > MeSH

MeSH Tree Structures - 2013

C20 - Immune System Diseases

• Immune System Diseases [C20]
  • Autoimmune Diseases [C20.111]
    • Addison Disease [C20.111.163]
    • Anemia, Hemolytic, Autoimmune [C20.111.175]
    • Anti-Glomerular Basement Membrane Disease [C20.111.190]
    • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis [C20.111.193]
      • Churg-Strauss Syndrome [C20.111.193.500]
      • Microscopic Polyangiitis [C20.111.193.750]
      • Wegener Granulomatosis [C20.111.193.875]
    • Antiphospholipid Syndrome [C20.111.197]
    • Arthritis, Rheumatoid [C20.111.199]
      • Arthritis, Juvenile Rheumatoid [C20.111.199.114]
      • Felty Syndrome [C20.111.199.389]
      • Rheumatoid Vasculitis [C20.111.199.581]
      • Sjogren's Syndrome [C20.111.199.774]
      • Still's Disease, Adult-Onset [C20.111.199.870]
    • Autoimmune Diseases of the Nervous System [C20.111.258]
      • Anti-N-Methyl-D-Aspartate Receptor Encephalitis [C20.111.258.124]
      • Demyelinating Autoimmune Diseases, CNS [C20.111.258.250]
        • Diffuse Cerebral Sclerosis of Schilder [C20.111.258.250.175]
        • Encephalomyelitis, Acute Disseminated [C20.111.258.250.350]
        • Leukoencephalitis, Acute Hemorrhagic [C20.111.258.250.425]
        • Multiple Sclerosis [C20.111.258.250.500]
          • Multiple Sclerosis, Chronic Progressive [C20.111.258.250.500.200]
          • Multiple Sclerosis, Relapsing-Remitting [C20.111.258.250.500.600]
          • Neuromyelitis Optica [C20.111.258.250.500.650]
        • Myelitis, Transverse [C20.111.258.250.550]
          • Neuromyelitis Optica [C20.111.258.250.550.500]
        • Neuromyelitis Optica [C20.111.258.250.600]
      • Lambert-Eaton Myasthenic Syndrome [C20.111.258.350]
      • Leukoencephalitis, Acute Hemorrhagic [C20.111.258.450]
      • Myasthenia Gravis [C20.111.258.500]
        • Myasthenia Gravis, Autoimmune, Experimental [C20.111.258.500.300]
        • Myasthenia Gravis, Neonatal [C20.111.258.500.650]
      • Nervous System Autoimmune Disease, Experimental [C20.111.258.625]
        • Encephalomyelitis, Autoimmune, Experimental [C20.111.258.625.300]
        • Myasthenia Gravis, Autoimmune, Experimental [C20.111.258.625.350]
        • Neuritis, Autoimmune, Experimental [C20.111.258.625.700]
      • Polyradiculoneuropathy [C20.111.258.750]
        • Guillain-Barre Syndrome [C20.111.258.750.400]
          • Miller Fisher Syndrome [C20.111.258.750.400.500]
        • Hereditary Sensory and Autonomic Neuropathies [C20.111.258.750.600]
          • Dysautonomia, Familial [C20.111.258.750.600.250]
        • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating [C20.111.258.750.800]
      • Stiff-Person Syndrome [C20.111.258.850]
      • Uveomeningoencephalitic Syndrome [C20.111.258.925]
      • Vasculitis, Central Nervous System [C20.111.258.962]
        • Giant Cell Arteritis [C20.111.258.962.800]
        • Lupus Vasculitis, Central Nervous System [C20.111.258.962.900]
    • Autoimmune Lymphoproliferative Syndrome [C20.111.288]
    • Dermatitis Herpetiformis [C20.111.318]
    • Diabetes Mellitus, Type 1 [C20.111.327]
    • Glomerulonephritis, IGA [C20.111.525]
    • Glomerulonephritis, Membranous [C20.111.535]
    • Graves Disease [C20.111.555]
      • Graves Ophthalmopathy [C20.111.555.500]
    • Hepatitis, Autoimmune [C20.111.567]
    • Lambert-Eaton Myasthenic Syndrome [C20.111.580]
    • Linear IgA Bullous Dermatosis [C20.111.585]
    • Lupus Erythematosus, Systemic [C20.111.590]
      • Lupus Nephritis [C20.111.590.560]
      • Lupus Vasculitis, Central Nervous System [C20.111.590.750]
    • Ophthalmia, Sympathetic [C20.111.709]
    • Pemphigoid, Bullous [C20.111.730]
    • Pemphigus [C20.111.736]
    • Polyendocrinopathies, Autoimmune [C20.111.750]
    • Purpura, Thrombocytopenic, Idiopathic [C20.111.759]
    • Thyroiditis, Autoimmune [C20.111.809]
  • Blood Group Incompatibility [C20.188]
    • Erythroblastosis, Fetal [C20.188.413]
      • Hydrops Fetalis [C20.188.413.480]
      • Kernicterus [C20.188.413.502]
    • Rh Isoimmunization [C20.188.780]
  • Glomerulonephritis, Membranoproliferative [C20.425]
  • Graft vs Host Disease [C20.452]
  • Hypersensitivity [C20.543]
    • Drug Hypersensitivity [C20.543.206]
      • Asthma, Aspirin-Induced [C20.543.206.189]
      • Drug Eruptions [C20.543.206.380]
        • Epidermal Necrolysis, Toxic [C20.543.206.380.350]
        • Erythema Nodosum [C20.543.206.380.375]
        • Serum Sickness [C20.543.206.380.800]
    • Environmental Illness [C20.543.312]
      • Multiple Chemical Sensitivity [C20.543.312.500]
      • Sick Building Syndrome [C20.543.312.750]
    • Hypersensitivity, Delayed [C20.543.418]
      • Dermatitis, Allergic Contact [C20.543.418.150]
        • Dermatitis, Photoallergic [C20.543.418.150.600]
        • Dermatitis, Toxicodendron [C20.543.418.150.700]
    • Hypersensitivity, Immediate [C20.543.480]
      • Anaphylaxis [C20.543.480.099]
      • Asthma, Aspirin-Induced [C20.543.480.149]
      • Conjunctivitis, Allergic [C20.543.480.200]
      • Dermatitis, Atopic [C20.543.480.343]
      • Eosinophilic Esophagitis [C20.543.480.356]
      • Food Hypersensitivity [C20.543.480.370]
        • Egg Hypersensitivity [C20.543.480.370.150]
        • Milk Hypersensitivity [C20.543.480.370.500]
        • Nut Hypersensitivity [C20.543.480.370.550]
        • Peanut Hypersensitivity [C20.543.480.370.675]
        • Wheat Hypersensitivity [C20.543.480.370.850]
      • Respiratory Hypersensitivity [C20.543.480.680]
        • Alveolitis, Extrinsic Allergic [C20.543.480.680.075]
          • Bird Fancier's Lung [C20.543.480.680.075.125]
          • Farmer's Lung [C20.543.480.680.075.365]
          • Trichosporonosis [C20.543.480.680.075.682]
        • Aspergillosis, Allergic Bronchopulmonary [C20.543.480.680.085]
        • Asthma [C20.543.480.680.095]
          • Asthma, Exercise-Induced [C20.543.480.680.095.110]
          • Asthma, Occupational [C20.543.480.680.095.495]
          • Status Asthmaticus [C20.543.480.680.095.880]
        • Rhinitis, Allergic, Perennial [C20.543.480.680.791]
        • Rhinitis, Allergic, Seasonal [C20.543.480.680.795]
      • Urticaria [C20.543.480.904]
        • Angioedema [C20.543.480.904.066]
          • Angioedemas, Hereditary [C20.543.480.904.066.500]
            • Hereditary Angioedema Type III [C20.543.480.904.066.500.500]
            • Hereditary Angioedema Types I and II [C20.543.480.904.066.500.750]
    • Immune Complex Diseases [C20.543.520]
      • Arthus Reaction [C20.543.520.100]
      • Purpura, Schoenlein-Henoch [C20.543.520.600]
      • Serum Sickness [C20.543.520.770]
      • Vasculitis, Leukocytoclastic, Cutaneous [C20.543.520.910]
    • Latex Hypersensitivity [C20.543.600]
    • Wissler's Syndrome [C20.543.928]
  • Immune Reconstitution Inflammatory Syndrome [C20.608]
  • Immunologic Deficiency Syndromes [C20.673]
    • Agammaglobulinemia [C20.673.088]
    • Ataxia Telangiectasia [C20.673.290]
    • Common Variable Immunodeficiency [C20.673.330]
    • Dysgammaglobulinemia [C20.673.430]
      • Hyper-IgM Immunodeficiency Syndrome [C20.673.430.249]
        • Hyper-IgM Immunodeficiency Syndrome, Type 1 [C20.673.430.249.500]
      • IgA Deficiency [C20.673.430.500]
      • IgG Deficiency [C20.673.430.750]
    • HIV Infections [C20.673.480]
      • Acquired Immunodeficiency Syndrome [C20.673.480.040]
      • AIDS Arteritis, Central Nervous System [C20.673.480.048]
      • AIDS-Associated Nephropathy [C20.673.480.050]
      • AIDS Dementia Complex [C20.673.480.070]
      • AIDS-Related Complex [C20.673.480.080]
      • AIDS-Related Opportunistic Infections [C20.673.480.100]
      • HIV-Associated Lipodystrophy Syndrome [C20.673.480.400]
      • HIV Enteropathy [C20.673.480.480]
      • HIV Seropositivity [C20.673.480.500]
      • HIV Wasting Syndrome [C20.673.480.520]
    • Deltaretrovirus Infections [C20.673.483]
      • Enzootic Bovine Leukosis [C20.673.483.260]
      • HTLV-I Infections [C20.673.483.470]
      • HTLV-II Infections [C20.673.483.480]
    • Leukocyte-Adhesion Deficiency Syndrome [C20.673.600]
    • Lymphopenia [C20.673.627]
      • T-Lymphocytopenia, Idiopathic CD4-Positive [C20.673.627.800]
      • Wiskott-Aldrich Syndrome [C20.673.627.900]
    • Phagocyte Bactericidal Dysfunction [C20.673.774]
      • Chediak-Higashi Syndrome [C20.673.774.257]
        • Aleutian Mink Disease [C20.673.774.257.270]
      • Granulomatous Disease, Chronic [C20.673.774.535]
      • Job's Syndrome [C20.673.774.600]
    • Severe Combined Immunodeficiency [C20.673.815]
      • X-Linked Combined Immunodeficiency Diseases [C20.673.815.500]
    • Wiskott-Aldrich Syndrome [C20.673.972]
  • Immunoproliferative Disorders [C20.683]
    • Hypergammaglobulinemia [C20.683.460]
      • Mevalonate Kinase Deficiency [C20.683.460.319]
      • Monoclonal Gammopathy of Undetermined Significance [C20.683.460.640]
    • Lymphoproliferative Disorders [C20.683.515]
      • Autoimmune Lymphoproliferative Syndrome [C20.683.515.124]
      • Giant Lymph Node Hyperplasia [C20.683.515.250]
      • Immunoblastic Lymphadenopathy [C20.683.515.501]
      • Immunoproliferative Small Intestinal Disease [C20.683.515.512]
      • Infectious Mononucleosis [C20.683.515.515]
      • Leukemia, Hairy Cell [C20.683.515.517]
      • Leukemia, Lymphoid [C20.683.515.528]
        • Leukemia, B-Cell [C20.683.515.528.080]
          • Leukemia, Lymphocytic, Chronic, B-Cell [C20.683.515.528.080.125]
          • Leukemia, Prolymphocytic, B-Cell [C20.683.515.528.080.562]
        • Leukemia, Biphenotypic, Acute [C20.683.515.528.100]
        • Leukemia, Prolymphocytic [C20.683.515.528.565]
          • Leukemia, Prolymphocytic, B-Cell [C20.683.515.528.565.745]
          • Leukemia, Prolymphocytic, T-Cell [C20.683.515.528.565.750]
        • Leukemia, T-Cell [C20.683.515.528.582]
          • Leukemia, Large Granular Lymphocytic [C20.683.515.528.582.049]
          • Leukemia-Lymphoma, Adult T-Cell [C20.683.515.528.582.100]
          • Leukemia, Prolymphocytic, T-Cell [C20.683.515.528.582.125]
        • Precursor Cell Lymphoblastic Leukemia-Lymphoma [C20.683.515.528.600]
          • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma [C20.683.515.528.600.600]
          • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma [C20.683.515.528.600.620]
      • Lymphangiomyoma [C20.683.515.710]
        • Lymphangioleiomyomatosis [C20.683.515.710.465]
      • Lymphoma [C20.683.515.761]
        • Composite Lymphoma [C20.683.515.761.150]
        • Hodgkin Disease [C20.683.515.761.355]
        • Lymphoma, Non-Hodgkin [C20.683.515.761.480]
          • Burkitt Lymphoma [C20.683.515.761.480.100]
          • Lymphoma, B-Cell [C20.683.515.761.480.150]
            • Burkitt Lymphoma [C20.683.515.761.480.150.165]
            • Lymphoma, AIDS-Related [C20.683.515.761.480.150.450]
            • Lymphoma, B-Cell, Marginal Zone [C20.683.515.761.480.150.570]
            • Lymphoma, Large B-Cell, Diffuse [C20.683.515.761.480.150.585]
            • Lymphoma, Primary Effusion [C20.683.515.761.480.150.592]
            • Lymphomatoid Granulomatosis [C20.683.515.761.480.150.600]
          • Lymphoma, Follicular [C20.683.515.761.480.350]
          • Lymphoma, Large-Cell, Immunoblastic [C20.683.515.761.480.487]
          • Lymphoma, Mantle-Cell [C20.683.515.761.480.525]
          • Lymphoma, T-Cell [C20.683.515.761.480.750]
            • Enteropathy-Associated T-Cell Lymphoma [C20.683.515.761.480.750.199]
            • Lymphoma, Large-Cell, Anaplastic [C20.683.515.761.480.750.399]
            • Lymphoma, T-Cell, Cutaneous [C20.683.515.761.480.750.800]
              • Lymphoma, Primary Cutaneous Anaplastic Large Cell [C20.683.515.761.480.750.800.507]
              • Lymphomatoid Papulosis [C20.683.515.761.480.750.800.528]
              • Mycosis Fungoides [C20.683.515.761.480.750.800.550]
                • Pagetoid Reticulosis [C20.683.515.761.480.750.800.550.600]
              • Sezary Syndrome [C20.683.515.761.480.750.800.775]
            • Lymphoma, T-Cell, Peripheral [C20.683.515.761.480.750.825]
      • Macrophage Activation Syndrome [C20.683.515.800]
      • Marek Disease [C20.683.515.840]
      • Multiple Myeloma [C20.683.515.845]
        • Leukemia, Plasma Cell [C20.683.515.845.500]
      • Plasmacytoma [C20.683.515.880]
      • Sezary Syndrome [C20.683.515.920]
      • Tumor Lysis Syndrome [C20.683.515.950]
    • Paraproteinemias [C20.683.780]
      • Cryoglobulinemia [C20.683.780.250]
      • Heavy Chain Disease [C20.683.780.490]
        • Immunoproliferative Small Intestinal Disease [C20.683.780.490.512]
      • Monoclonal Gammopathy of Undetermined Significance [C20.683.780.640]
        • Schnitzler Syndrome [C20.683.780.640.700]
      • Multiple Myeloma [C20.683.780.650]
      • POEMS Syndrome [C20.683.780.750]
      • Waldenstrom Macroglobulinemia [C20.683.780.925]
  • Purpura, Thrombocytopenic [C20.841]
    • Purpura, Thrombocytopenic, Idiopathic [C20.841.600]

Copyright, Privacy, Accessibility, Site Map, Viewers and Players
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act, Contact Us

Last updated: 21 August 2012
First published: 21 August 2012
Metadata| Permanence level: Permanent: Dynamic Content